Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study
Molecules · 2023
DOI: 10.3390/molecules28073223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jeong-Hyeon Lim und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Albumins, Immunoprecipitation, Irinotecan, Liquid Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chungnam National University.
Abstract (Originalsprache)
There have been many attempts in pharmaceutical industries and academia to improve the pharmacokinetic characteristics of anti-tumor small-molecule drugs by conjugating them with large molecules, such as monoclonal antibodies, called ADCs. In this context, albumin, one of the most abundant proteins in the blood, has also been proposed as a large molecule to be conjugated with anti-cancer small-molecule drugs. The half-life of albumin is 3 weeks in humans, and its distribution to tumors is higher than in normal tissues. However, few studies have been conducted for the in vivo prepared albumin-drug conjugates, possibly due to the lack of robust bioanalytical methods, which are critical for evaluating the ADME/PK properties of in vivo prepared albumin-drug conjugates. In this study, we developed a bioanalytical method of the albumin-conjugated MAC glucuronide phenol linked SN-38 ((2S,3S,4S,5R,6S)-6-(4-(((((((S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano [3′,4′:6,7] indolizino [1,2-b] quinolin-9-yl)oxy)methyl)(2 (methylsulfonyl)ethyl)carbamoyl)oxy)methyl)-2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylpropanamido)acetamido)phenoxy)-3,4,5-trihydroxytetra-hydro-2H-pyran-2-carboxylic acid) as a proof-of-concept. This method is based on immunoprecipitation using magnetic beads and the quantification of albumin-conjugated drug concentration using LC-qTOF/MS in mouse plasma. Finally, the developed method was applied to the in vivo intravenous (IV) mouse pharmacokinetic study of MAC glucuronide phenol-linked SN-38.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
ORCID-Profile: Young G Shin
Förderung
- Chungnam National University
Zitieren
APA
Lim, J. H., Park, M., Park, Y., Park, S. J., Lee, J., Hwang, S., Lee, J., Lee, Y., Jo, E., & Shin, Y. G. (2023). Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study. Molecules. https://doi.org/10.3390/molecules28073223
Vancouver
Lim JH, Park M, Park Y, Park SJ, Lee J, Hwang S, et al. Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study. Molecules. 2023. doi:10.3390/molecules28073223
BibTeX
@article{Lim2023,
author = {Lim, Jeong-Hyeon and Park, Minjae and Park, Yuri and Park, Seo-Jin and Lee, Jiyu and Hwang, Sangsoo and Lee, Jeongmin and Lee, Yujin and Jo, Eunjeong and Shin, Young G},
title = {Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28073223}
}
EUVIMED